About BMC Research
BMC and the legacy organizations have a long history of research, both on a stand-alone basis and with others on the Medical Campus and elsewhere.
- Major contributions to discovery and science have been made on the medical campus including work associated with Nobel Prizes.
- We are focused on making BMC a preeminent center of research, regionally and nationally.
Research Program Highlights
- BMC is 15th in NIH Funding of 75 Independent Hospitals Nationwide
- $116 Million in Budgeted Sponsored Funding, $320 Million Collectively Across the Campus
- 228 Principal Investigators Working on 581 Projects
- 157,880 Net Sq. Ft. of Bench and Clinical Research Space
Our researchers received $116 million in grants in FY17 for a wide range of projects from care innovation to basic science, animal research and translational research:
- $3 Million NIH-NICHD Grant – Arvin Garg, MD (Social Determinants in Pediatrics)
- $2.9 Million NIH-NIAID Grant – Lee Wetzler, MD (Gonococcal Vaccine Evaluation)
- $2.1 Million PCORI Grant – Michael Silverstein, MD (Improving Outcomes for Low-Income Mothers with Depression)
- $1.7 Million Origin, Inc. Grant – Hau Pham, DPM, (Treatment of Diabetic Foot Ulcers)
- $1.7 Million NIH-NHLBI Grant – George Murphy, PhD (Sickle Cell Anemia)
- $1.7 Million NIH-NIDA Grant – Jeffrey Samet, MD (Clinical Addiction Research & Education Program)
- $1.5 Million W.K. Kellogg Foundation Grant – Anne Merewood, PhD (Mississippi CHAMPS)
- $1.5 Million Leidos Grant – Christopher Andry, PhD (Thrombosis-Related Biomarkers in Cancer Patient)
The Center for Regenerative Medicine (CReM) for stem cell research houses one of the largest iPS cell banks in the world. Strong BUSM/BMC collaboration.
In July, 2014, Boston Medical Center was awarded a $19 million dollar seven year grant from the National Institutes of Health for the TB Research Unit (TBRU).
Boston Obesity Nutrition Research Center – collaboration of four major institutions
Programs and Research Centers
The Center for Regenerative Medicine (CReM) for stem cell research houses one of the largest iPS cell banks in the world.
In July, 2014, Boston Medical Center was the recipient of a $19 million dollar award over 7 years from the National Institutes of Health for the TB Research Unit (TBRU) Program. The TBRU at Boston Medical Center uses animal models and clinical studies to discover mechanisms and markers of progression from infection with Mycobacterium tuberculosis to active disease and for persistence of bacteria after treatment and risk of relapse. The program is complex, multidisciplinary and global. A host marker for risk of TB would be an enormous public health tool for TB control and allow targeting of treatment of latent TB infection.
The Boston Obesity Nutrition Research Center, administratively based at BMC, is a collaboration of four major institutions that provides resources and support for studies in the area of obesity and nutrition. In the past five years alone, Boston Obesity Center investigators published more than 300 papers with Center support.
Violence Intervention Advocacy Program (VIAP): Founded in 2006, VIAP is a co-founder of the National Network of Hospital Based Violence Intervention Programs (NNHVIP), which has grown to more than 28 programs nationwide and internationally. VIAP assigns victims of community violence and their family member(s) a Violence Intervention Advocate and a Family Support Coordinator to assist in providing comprehensive, trauma informed, 360 degree care. This program recently received an award from the Department of Justice.
Pathology Tumor Registry Project. In 2011, the Boston Medical Center’s Tumor Registry Group in Pathology became one of the National Cancer Institute’s (“NCI’s”) biospecimen resource sites for cancer biospecimens, in order to provide prospectively collected, clinically annotated cancer biospecimens from consented patient cases to the federal cancer Human Biobank Centers at NCI. These biospecimens will be used to find markers for colon, breast, lung and prostate cancers, and it is hoped that it will enhance early diagnosis of these conditions in patients.
Center of Excellence in Sickle Cell Disease. The Center of Excellence in Sickle Cell Disease (“CESCD”) promotes interactive basic and clinical research and patient and professional educational activities. NIH-supported research projects at CESCD focus on the genetic modulation of sickle cell disease, the biology and treatment of sickle cell pulmonary hypertension, and the development of new agents that modulate hemoglobin expression in sickle cell disease.